Clene Inc.·4

Feb 20, 4:04 PM ET

MATLIN DAVID J 4

4 · Clene Inc. · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Clene (CLNN) Director David J. Matlin Receives Stock Option Award

What Happened

  • David J. Matlin, a director of Clene Inc. (CLNN), received a grant of options for 5,372 shares of common stock on February 19, 2026.
  • The options carry an exercise (strike) price of $4.73 per share (total exercise cost ≈ $25,412 if exercised) and were granted under the Clene Inc. Amended 2020 Stock Plan. The options vest immediately upon grant.
  • This was an award of derivative securities (options), not an open‑market purchase or sale; it represents potential future equity if Matlin chooses to exercise the options and pay the strike price.

Key Details

  • Transaction date: 2026-02-19; Filing date: 2026-02-20 (timely filing).
  • Security: option to acquire 5,372 shares of common stock; exercise price $4.73 per share.
  • Footnote: Grant made under Clene’s Amended 2020 Stock Plan; options vest immediately.
  • Shares owned after transaction: not specified in the provided filing summary.
  • Transaction code: A (award/grant); classified as a derivative grant in the Form 4.

Context

  • This grant is compensatory (an equity award) rather than an outright purchase or sale. It creates potential future ownership if exercised — the director would need to pay the $4.73 strike price per share to convert options into common stock.
  • Immediate vesting means the award is not subject to a future service-based vesting schedule; however, it does not indicate whether Matlin will exercise the options or sell any resulting shares.
  • Such awards are common for directors and often form part of regular compensation. They provide potential upside aligned with future stock performance but are not a direct buy signal.

Insider Transaction Report

Form 4
Period: 2026-02-19
Transactions
  • Award

    stock option

    [F1]
    2026-02-19+5,3725,372 total
    Exercise: $4.73Exp: 2036-02-18common stock (5,372 underlying)
Footnotes (1)
  • [F1]This option was granted on February 19, 2026 as an option for 5,372 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.
Signature
/s/ Jerome T. Miraglia POA|2026-02-20

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4